English
简体中文
Total: £ 56.28
Published Date: 2026-01-30 | Pages: 126 | Tables: 126 | Pharma & Healthcare
The global Coccidiosis Vaccines market was valued at US$ 176 million in 2025 and is anticipated to reach US$ 244 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Coccidiosis Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Coccidiosis vaccines are biological preparations aimed at preventing coccidiosis, a parasitic disease primarily affecting livestock and poultry, particularly chickens. This disease is caused by various species of protozoan parasites from the genus Eimeria, which infect the intestinal lining, leading to symptoms such as diarrhea, weight loss, and decreased feed efficiency. Coccidiosis vaccines typically contain live attenuated or killed strains of Eimeria parasites, which stimulate the host's immune system to develop protective immunity against future infections.
Coccidiosis is one of the most common parasitic diseases in the poultry industry, primarily caused by Eimeria species. This disease poses a significant threat to poultry health and can lead to a notable decrease in production performance, even resulting in death. Traditionally, the poultry industry has relied on anticoccidial drugs for prevention and treatment, but with the increasing problem of drug resistance, the over-reliance on anticoccidial medications is gradually being challenged. As a result, coccidiosis vaccines have become an important alternative to drug treatments.
The vaccine works by simulating a coccidial infection, triggering an immune response in the poultry's system, thereby enhancing immunity against future infections. Unlike drug treatments, vaccines effectively reduce the dependence on antibiotics, help curb the development of resistance, and promote a more sustainable and environmentally friendly poultry industry. The use of coccidiosis vaccines not only reduces the incidence and mortality of infections in poultry flocks but also improves production performance, such as weight gain in broilers and egg production in layers.
In recent years, with continuous innovation in vaccine technology, the types and effectiveness of coccidiosis vaccines have significantly improved. There are now many types of coccidiosis vaccines on the market, including attenuated live vaccines, inactivated vaccines, and recombinant and multivalent vaccines currently under development. These new-generation vaccines can target different species of Eimeria and offer stronger immune protection.
The demand for coccidiosis vaccines has gradually increased in recent years, mainly due to the rising consumer demand for antibiotic-free food and increased awareness of animal welfare and environmental protection. With the global trend towards larger-scale and more intensive poultry farming, the use of vaccines has become a key method for ensuring the health and sustainable development of poultry production.
Especially in the European and American markets, an increasing number of poultry farms are gradually eliminating anticoccidial drugs and turning to vaccines for prevention and treatment. This shift has contributed to the rapid growth of the vaccine market. In the Asia-Pacific region, particularly in countries such as China, India, and Southeast Asia, with the rapid development of poultry farming, the demand for coccidiosis vaccines is also increasing. More countries and regions are beginning to implement strict drug residue regulations, which has further driven the use of vaccines as an alternative solution.
This report delivers a comprehensive overview of the global Coccidiosis Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Coccidiosis Vaccines. The Coccidiosis Vaccines market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Coccidiosis Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Coccidiosis Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
MSD Animal Health
Boehringer Ingelheim
HIPRA
Bioproperties
Huvepharma
Nisseiken
Biopharm
Ceva Santé Animale
Vaxxinova
Foshan Standard Biotech
Qilu Qingda Bio-Pharmaceutical
Skystar Bio-pharm
Hlinte
Guangdong Winsun Bio-pharmaceutical
Segment by Type
Attenuated Vaccines
Non-attenuated Vaccines
by Application
Poultry
Rabbit
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Coccidiosis Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Coccidiosis Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Coccidiosis Vaccines Market Overview
1.1 Product Definition
1.2 Coccidiosis Vaccines by Type
1.2.1 Global Coccidiosis Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Attenuated Vaccines
1.2.3 Non-attenuated Vaccines
1.3 Coccidiosis Vaccines by Application
1.3.1 Global Coccidiosis Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Poultry
1.3.3 Rabbit
1.3.4 Others
1.4 Global Coccidiosis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Coccidiosis Vaccines Revenue 2021–2032
1.4.2 Global Coccidiosis Vaccines Sales 2021–2032
1.4.3 Global Coccidiosis Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Coccidiosis Vaccines Market Competition by Manufacturers
2.1 Global Coccidiosis Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Coccidiosis Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Coccidiosis Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Coccidiosis Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Coccidiosis Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Coccidiosis Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Coccidiosis Vaccines, Date of Entry into the Industry
2.8 Global Coccidiosis Vaccines Market Competitive Situation and Trends
2.8.1 Global Coccidiosis Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Coccidiosis Vaccines Players Market Share by Revenue
2.8.3 Global Coccidiosis Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Coccidiosis Vaccines Market Scenario by Region
3.1 Global Coccidiosis Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Coccidiosis Vaccines Sales by Region: 2021–2032
3.2.1 Global Coccidiosis Vaccines Sales by Region: 2021–2026
3.2.2 Global Coccidiosis Vaccines Sales by Region: 2027–2032
3.3 Global Coccidiosis Vaccines Revenue by Region: 2021–2032
3.3.1 Global Coccidiosis Vaccines Revenue by Region: 2021–2026
3.3.2 Global Coccidiosis Vaccines Revenue by Region: 2027–2032
3.4 North America Coccidiosis Vaccines Market Facts & Figures by Country
3.4.1 North America Coccidiosis Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Coccidiosis Vaccines Sales by Country (2021–2032)
3.4.3 North America Coccidiosis Vaccines Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coccidiosis Vaccines Market Facts & Figures by Country
3.5.1 Europe Coccidiosis Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Coccidiosis Vaccines Sales by Country (2021–2032)
3.5.3 Europe Coccidiosis Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coccidiosis Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Coccidiosis Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Coccidiosis Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Coccidiosis Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Coccidiosis Vaccines Market Facts & Figures by Country
3.7.1 Latin America Coccidiosis Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Coccidiosis Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Coccidiosis Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Coccidiosis Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Coccidiosis Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Coccidiosis Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Coccidiosis Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coccidiosis Vaccines Sales by Type (2021–2032)
4.1.1 Global Coccidiosis Vaccines Sales by Type (2021–2026)
4.1.2 Global Coccidiosis Vaccines Sales by Type (2027–2032)
4.1.3 Global Coccidiosis Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Coccidiosis Vaccines Revenue by Type (2021–2032)
4.2.1 Global Coccidiosis Vaccines Revenue by Type (2021–2026)
4.2.2 Global Coccidiosis Vaccines Revenue by Type (2027–2032)
4.2.3 Global Coccidiosis Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Coccidiosis Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Coccidiosis Vaccines Sales by Application (2021–2032)
5.1.1 Global Coccidiosis Vaccines Sales by Application (2021–2026)
5.1.2 Global Coccidiosis Vaccines Sales by Application (2027–2032)
5.1.3 Global Coccidiosis Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Coccidiosis Vaccines Revenue by Application (2021–2032)
5.2.1 Global Coccidiosis Vaccines Revenue by Application (2021–2026)
5.2.2 Global Coccidiosis Vaccines Revenue by Application (2027–2032)
5.2.3 Global Coccidiosis Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Coccidiosis Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MSD Animal Health Coccidiosis Vaccines Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Coccidiosis Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 HIPRA
6.3.1 HIPRA Company Information
6.3.2 HIPRA Description and Business Overview
6.3.3 HIPRA Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 HIPRA Coccidiosis Vaccines Product Portfolio
6.3.5 HIPRA Recent Developments/Updates
6.4 Bioproperties
6.4.1 Bioproperties Company Information
6.4.2 Bioproperties Description and Business Overview
6.4.3 Bioproperties Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bioproperties Coccidiosis Vaccines Product Portfolio
6.4.5 Bioproperties Recent Developments/Updates
6.5 Huvepharma
6.5.1 Huvepharma Company Information
6.5.2 Huvepharma Description and Business Overview
6.5.3 Huvepharma Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Huvepharma Coccidiosis Vaccines Product Portfolio
6.5.5 Huvepharma Recent Developments/Updates
6.6 Nisseiken
6.6.1 Nisseiken Company Information
6.6.2 Nisseiken Description and Business Overview
6.6.3 Nisseiken Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nisseiken Coccidiosis Vaccines Product Portfolio
6.6.5 Nisseiken Recent Developments/Updates
6.7 Biopharm
6.7.1 Biopharm Company Information
6.7.2 Biopharm Description and Business Overview
6.7.3 Biopharm Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Biopharm Coccidiosis Vaccines Product Portfolio
6.7.5 Biopharm Recent Developments/Updates
6.8 Ceva Santé Animale
6.8.1 Ceva Santé Animale Company Information
6.8.2 Ceva Santé Animale Description and Business Overview
6.8.3 Ceva Santé Animale Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ceva Santé Animale Coccidiosis Vaccines Product Portfolio
6.8.5 Ceva Santé Animale Recent Developments/Updates
6.9 Vaxxinova
6.9.1 Vaxxinova Company Information
6.9.2 Vaxxinova Description and Business Overview
6.9.3 Vaxxinova Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Vaxxinova Coccidiosis Vaccines Product Portfolio
6.9.5 Vaxxinova Recent Developments/Updates
6.10 Foshan Standard Biotech
6.10.1 Foshan Standard Biotech Company Information
6.10.2 Foshan Standard Biotech Description and Business Overview
6.10.3 Foshan Standard Biotech Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Foshan Standard Biotech Coccidiosis Vaccines Product Portfolio
6.10.5 Foshan Standard Biotech Recent Developments/Updates
6.11 Qilu Qingda Bio-Pharmaceutical
6.11.1 Qilu Qingda Bio-Pharmaceutical Company Information
6.11.2 Qilu Qingda Bio-Pharmaceutical Description and Business Overview
6.11.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product Portfolio
6.11.5 Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates
6.12 Skystar Bio-pharm
6.12.1 Skystar Bio-pharm Company Information
6.12.2 Skystar Bio-pharm Description and Business Overview
6.12.3 Skystar Bio-pharm Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Skystar Bio-pharm Coccidiosis Vaccines Product Portfolio
6.12.5 Skystar Bio-pharm Recent Developments/Updates
6.13 Hlinte
6.13.1 Hlinte Company Information
6.13.2 Hlinte Description and Business Overview
6.13.3 Hlinte Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hlinte Coccidiosis Vaccines Product Portfolio
6.13.5 Hlinte Recent Developments/Updates
6.14 Guangdong Winsun Bio-pharmaceutical
6.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
6.14.2 Guangdong Winsun Bio-pharmaceutical Description and Business Overview
6.14.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product Portfolio
6.14.5 Guangdong Winsun Bio-pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coccidiosis Vaccines Industry Chain Analysis
7.2 Coccidiosis Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coccidiosis Vaccines Production Mode & Process Analysis
7.4 Coccidiosis Vaccines Sales and Marketing
7.4.1 Coccidiosis Vaccines Sales Channels
7.4.2 Coccidiosis Vaccines Distributors
7.5 Coccidiosis Vaccines Customer Analysis
8 Coccidiosis Vaccines Market Dynamics
8.1 Coccidiosis Vaccines Industry Trends
8.2 Coccidiosis Vaccines Market Drivers
8.3 Coccidiosis Vaccines Market Challenges
8.4 Coccidiosis Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Coccidiosis Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Coccidiosis Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Coccidiosis Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Coccidiosis Vaccines Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Coccidiosis Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Coccidiosis Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Coccidiosis Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Coccidiosis Vaccines Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Coccidiosis Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Coccidiosis Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Coccidiosis Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Coccidiosis Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Coccidiosis Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Coccidiosis Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Coccidiosis Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Coccidiosis Vaccines Sales by Region (K Units), 2021–2026
Table 18. Global Coccidiosis Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Coccidiosis Vaccines Sales by Region (K Units), 2027–2032
Table 20. Global Coccidiosis Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Coccidiosis Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Coccidiosis Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Coccidiosis Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Coccidiosis Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Coccidiosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Coccidiosis Vaccines Sales by Country (K Units), 2021–2026
Table 27. North America Coccidiosis Vaccines Sales by Country (K Units), 2027–2032
Table 28. North America Coccidiosis Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Coccidiosis Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Coccidiosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Coccidiosis Vaccines Sales by Country (K Units), 2021–2026
Table 32. Europe Coccidiosis Vaccines Sales by Country (K Units), 2027–2032
Table 33. Europe Coccidiosis Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Coccidiosis Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Coccidiosis Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Coccidiosis Vaccines Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Coccidiosis Vaccines Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Coccidiosis Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Coccidiosis Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Coccidiosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Coccidiosis Vaccines Sales by Country (K Units), 2021–2026
Table 42. Latin America Coccidiosis Vaccines Sales by Country (K Units), 2027–2032
Table 43. Latin America Coccidiosis Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Coccidiosis Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Coccidiosis Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Coccidiosis Vaccines Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Coccidiosis Vaccines Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Coccidiosis Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Coccidiosis Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Coccidiosis Vaccines Sales (K Units) by Type (2021–2026)
Table 51. Global Coccidiosis Vaccines Sales (K Units) by Type (2027–2032)
Table 52. Global Coccidiosis Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Coccidiosis Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Coccidiosis Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Coccidiosis Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Coccidiosis Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Coccidiosis Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Coccidiosis Vaccines Price (US$/Unit) by Type (2021–2026)
Table 59. Global Coccidiosis Vaccines Price (US$/Unit) by Type (2027–2032)
Table 60. Global Coccidiosis Vaccines Sales (K Units) by Application (2021–2026)
Table 61. Global Coccidiosis Vaccines Sales (K Units) by Application (2027–2032)
Table 62. Global Coccidiosis Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Coccidiosis Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Coccidiosis Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Coccidiosis Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Coccidiosis Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Coccidiosis Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Coccidiosis Vaccines Price (US$/Unit) by Application (2021–2026)
Table 69. Global Coccidiosis Vaccines Price (US$/Unit) by Application (2027–2032)
Table 70. MSD Animal Health Company Information
Table 71. MSD Animal Health Description and Business Overview
Table 72. MSD Animal Health Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. MSD Animal Health Coccidiosis Vaccines Product
Table 74. MSD Animal Health Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Boehringer Ingelheim Coccidiosis Vaccines Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. HIPRA Company Information
Table 81. HIPRA Description and Business Overview
Table 82. HIPRA Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. HIPRA Coccidiosis Vaccines Product
Table 84. HIPRA Recent Developments/Updates
Table 85. Bioproperties Company Information
Table 86. Bioproperties Description and Business Overview
Table 87. Bioproperties Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Bioproperties Coccidiosis Vaccines Product
Table 89. Bioproperties Recent Developments/Updates
Table 90. Huvepharma Company Information
Table 91. Huvepharma Description and Business Overview
Table 92. Huvepharma Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Huvepharma Coccidiosis Vaccines Product
Table 94. Huvepharma Recent Developments/Updates
Table 95. Nisseiken Company Information
Table 96. Nisseiken Description and Business Overview
Table 97. Nisseiken Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Nisseiken Coccidiosis Vaccines Product
Table 99. Nisseiken Recent Developments/Updates
Table 100. Biopharm Company Information
Table 101. Biopharm Description and Business Overview
Table 102. Biopharm Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Biopharm Coccidiosis Vaccines Product
Table 104. Biopharm Recent Developments/Updates
Table 105. Ceva Santé Animale Company Information
Table 106. Ceva Santé Animale Description and Business Overview
Table 107. Ceva Santé Animale Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Ceva Santé Animale Coccidiosis Vaccines Product
Table 109. Ceva Santé Animale Recent Developments/Updates
Table 110. Vaxxinova Company Information
Table 111. Vaxxinova Description and Business Overview
Table 112. Vaxxinova Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Vaxxinova Coccidiosis Vaccines Product
Table 114. Vaxxinova Recent Developments/Updates
Table 115. Foshan Standard Biotech Company Information
Table 116. Foshan Standard Biotech Description and Business Overview
Table 117. Foshan Standard Biotech Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Foshan Standard Biotech Coccidiosis Vaccines Product
Table 119. Foshan Standard Biotech Recent Developments/Updates
Table 120. Qilu Qingda Bio-Pharmaceutical Company Information
Table 121. Qilu Qingda Bio-Pharmaceutical Description and Business Overview
Table 122. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product
Table 124. Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates
Table 125. Skystar Bio-pharm Company Information
Table 126. Skystar Bio-pharm Description and Business Overview
Table 127. Skystar Bio-pharm Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Skystar Bio-pharm Coccidiosis Vaccines Product
Table 129. Skystar Bio-pharm Recent Developments/Updates
Table 130. Hlinte Company Information
Table 131. Hlinte Description and Business Overview
Table 132. Hlinte Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Hlinte Coccidiosis Vaccines Product
Table 134. Hlinte Recent Developments/Updates
Table 135. Guangdong Winsun Bio-pharmaceutical Company Information
Table 136. Guangdong Winsun Bio-pharmaceutical Description and Business Overview
Table 137. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product
Table 139. Guangdong Winsun Bio-pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Coccidiosis Vaccines Distributors List
Table 143. Coccidiosis Vaccines Customers List
Table 144. Coccidiosis Vaccines Market Trends
Table 145. Coccidiosis Vaccines Market Drivers
Table 146. Coccidiosis Vaccines Market Challenges
Table 147. Coccidiosis Vaccines Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Coccidiosis Vaccines
Figure 2. Global Coccidiosis Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Coccidiosis Vaccines Market Share by Type: 2025 & 2032
Figure 4. Attenuated Vaccines Product Picture
Figure 5. Non-attenuated Vaccines Product Picture
Figure 6. Global Coccidiosis Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Coccidiosis Vaccines Market Share by Application: 2025 & 2032
Figure 8. Poultry
Figure 9. Rabbit
Figure 10. Others
Figure 11. Global Coccidiosis Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Coccidiosis Vaccines Market Size (US$ Million), 2021–2032
Figure 13. Global Coccidiosis Vaccines Sales (K Units), 2021–2032
Figure 14. Global Coccidiosis Vaccines Average Price (US$/Unit), 2021–2032
Figure 15. Coccidiosis Vaccines Report Years Considered
Figure 16. Coccidiosis Vaccines Sales Share by Manufacturers in 2025
Figure 17. Global Coccidiosis Vaccines Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Coccidiosis Vaccines Players: Market Share by Revenue in Coccidiosis Vaccines in 2025
Figure 19. Coccidiosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Coccidiosis Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Coccidiosis Vaccines Sales Market Share by Country (2021–2032)
Figure 22. North America Coccidiosis Vaccines Revenue Market Share by Country (2021–2032)
Figure 23. United States Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Coccidiosis Vaccines Sales Market Share by Country (2021–2032)
Figure 26. Europe Coccidiosis Vaccines Revenue Market Share by Country (2021–2032)
Figure 27. Germany Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Coccidiosis Vaccines Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Coccidiosis Vaccines Revenue Market Share by Region (2021–2032)
Figure 34. China Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Coccidiosis Vaccines Sales Market Share by Country (2021–2032)
Figure 42. Latin America Coccidiosis Vaccines Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Coccidiosis Vaccines Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Coccidiosis Vaccines Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Coccidiosis Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Coccidiosis Vaccines by Type (2021–2032)
Figure 53. Global Revenue Market Share of Coccidiosis Vaccines by Type (2021–2032)
Figure 54. Global Coccidiosis Vaccines Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Coccidiosis Vaccines by Application (2021–2032)
Figure 56. Global Revenue Market Share of Coccidiosis Vaccines by Application (2021–2032)
Figure 57. Global Coccidiosis Vaccines Price (US$/Unit) by Application (2021–2032)
Figure 58. Coccidiosis Vaccines Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
